APA (7th ed.) Citation

JD, S., ST, d. V., DE, K., FF, H., & HJL, H. (2025). Sex differences in response to the endothelin receptor antagonist atrasentan in individuals with type 2 diabetes and chronic kidney disease: A post hoc analysis of the SONAR trial. Diabetologia, 68(3), 516. https://doi.org/10.1007/s00125-024-06326-x

Chicago Style (17th ed.) Citation

JD, Smeijer, de Vries ST, Kohan DE, Hou FF, and Heerspink HJL. "Sex Differences in Response to the Endothelin Receptor Antagonist Atrasentan in Individuals with Type 2 Diabetes and Chronic Kidney Disease: A Post Hoc Analysis of the SONAR Trial." Diabetologia 68, no. 3 (2025): 516. https://doi.org/10.1007/s00125-024-06326-x.

MLA (9th ed.) Citation

JD, Smeijer, et al. "Sex Differences in Response to the Endothelin Receptor Antagonist Atrasentan in Individuals with Type 2 Diabetes and Chronic Kidney Disease: A Post Hoc Analysis of the SONAR Trial." Diabetologia, vol. 68, no. 3, 2025, p. 516, https://doi.org/10.1007/s00125-024-06326-x.